Medical Properties Trust: Oppenheimer & Co. Inc. Reduces Holdings by 75.2%

Oppenheimer & Co. Inc. Sells Majority Stake in Medical Properties Trust

In a recent disclosure with the Securities and Exchange Commission (SEC), Oppenheimer & Co. Inc. revealed that it has significantly reduced its holdings in Medical Properties Trust, Inc. (NYSE:MPW). The institutional investor sold 75.2% of its stake in the real estate investment trust, amounting to 60,971 shares, leaving them with 20,079 shares valued at $94,000.

This move by Oppenheimer & Co. Inc. is part of a larger trend among hedge funds, with several others also adjusting their holdings of MPW. Charles Schwab Investment Management Inc., Coatue Management LLC, Lasalle Investment Management Securities LLC, Norges Bank, and Sumitomo Mitsui Trust Holdings Inc. have all made modifications to their positions in Medical Properties Trust.

Medical Properties Trust stock opened at $4.80 on Friday, with a fifty-day moving average price of $4.87 and a two-hundred day moving average price of $4.32. The company has a market cap of $2.88 billion and a beta of 1.27.

Additionally, Medical Properties Trust recently declared a quarterly dividend, with stockholders receiving a $0.15 dividend on July 9th. The ex-dividend date was June 10th, and the annualized dividend yield is 12.50%.

Analysts have weighed in on the company, with mixed ratings. Five analysts have rated the stock as sell, eight as hold, and one as buy. The consensus target price for Medical Properties Trust is $5.61.

Medical Properties Trust, Inc. is a self-advised real estate investment trust focused on acquiring and developing net-leased hospital facilities. With 441 facilities and approximately 44,000 licensed beds, the company has become one of the world’s largest owners of hospital real estate.

For more information on hedge fund holdings and insider trades related to Medical Properties Trust, visit HoldingsChannel.com.